{"id":"highly-active-antiretroviral-therapy","safety":{"commonSideEffects":[{"rate":"20-40","effect":"Nausea and gastrointestinal disturbances"},{"rate":"10-30","effect":"Lipodystrophy (fat redistribution)"},{"rate":"15-30","effect":"Peripheral neuropathy"},{"rate":"5-15","effect":"Hepatotoxicity"},{"rate":"20-50","effect":"Hyperlipidemia"},{"rate":"10-25","effect":"Hyperglycemia"},{"rate":"5-15","effect":"Rash"},{"rate":"<1","effect":"Lactic acidosis (rare but serious)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"HAART typically combines nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), and/or protease inhibitors (PIs) to block HIV reverse transcription and protease activity. This multi-drug approach prevents the virus from replicating and reduces viral load to undetectable levels, allowing immune system recovery and preventing disease progression to AIDS.","oneSentence":"HAART uses a combination of antiretroviral drugs from different classes to suppress HIV replication by targeting multiple steps of the viral lifecycle simultaneously.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:22:34.871Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"HIV-1 infection (treatment and suppression)"},{"name":"Prevention of mother-to-child HIV transmission"},{"name":"Post-exposure prophylaxis (PEP) in certain regimens"}]},"trialDetails":[{"nctId":"NCT07476339","phase":"PHASE4","title":"REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE: A Multi-Center, Single-Arm, Open-Label, Phase 4 Study Assessing the Safety and Efficacy of B/F/TAF in HIV-Positive Adults Returning to Care After Experiencing a Treatment Interruption of ≥12 Weeks","status":"NOT_YET_RECRUITING","sponsor":"CAN Community Health","startDate":"2026-03-23","conditions":"HIV -1 Infection, HIV (Human Immunodeficiency Virus), HIV","enrollment":200},{"nctId":"NCT07202546","phase":"PHASE2","title":"A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)","status":"RECRUITING","sponsor":"ViiV Healthcare","startDate":"2026-02-11","conditions":"HIV Infections","enrollment":150},{"nctId":"NCT06629753","phase":"NA","title":"Differentiated Service Delivery for Pregnant and Postpartum Women Living With HIV and Their Infants","status":"COMPLETED","sponsor":"Indiana University","startDate":"2024-09-13","conditions":"Hiv, Transmission Vertical, Viremia","enrollment":278},{"nctId":"NCT07209267","phase":"PHASE2","title":"Baricitinib Curative Repression of HIV-1","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-03","conditions":"HIV Infection, HIV","enrollment":20},{"nctId":"NCT03497676","phase":"PHASE1, PHASE2","title":"More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-04-03","conditions":"HIV Infections","enrollment":168},{"nctId":"NCT07357584","phase":"PHASE4","title":"Efficacy and Safety of Doravirine in the Rapid Initiation","status":"NOT_YET_RECRUITING","sponsor":"Fundación Huésped","startDate":"2026-07-13","conditions":"HIV-1-infection","enrollment":100},{"nctId":"NCT02969915","phase":"NA","title":"Strategies to Improve the HIV Care Continuum Among Key Populations in India","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2017-10-30","conditions":"HIV Infections","enrollment":2314},{"nctId":"NCT06317051","phase":"PHASE3","title":"Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kirby Institute","startDate":"2024-12-16","conditions":"HIV Infections, Weight Gain","enrollment":300},{"nctId":"NCT07115368","phase":"PHASE1","title":"Study of GS-1219 in Participants With HIV-1","status":"TERMINATED","sponsor":"Gilead Sciences","startDate":"2025-08-11","conditions":"HIV-1-infection","enrollment":4},{"nctId":"NCT06039579","phase":"PHASE2","title":"Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected Adults","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2023-10-25","conditions":"HIV Infections","enrollment":44},{"nctId":"NCT07110831","phase":"PHASE4","title":"Disposition Kinetics of Dolutegravir Among People Living With HIV With Major Depression in Nigeria","status":"NOT_YET_RECRUITING","sponsor":"University of Ibadan","startDate":"2025-08-14","conditions":"Depression, HIV","enrollment":168},{"nctId":"NCT04087239","phase":"","title":"The University of Zimbabwe College of Health Science (UZ-CHS) BIRTH COHORT Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Zimbabwe","startDate":"2016-01-26","conditions":"HIV Infections, Immune Activation, Comorbidities","enrollment":1200},{"nctId":"NCT05898841","phase":"PHASE4","title":"Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Load","status":"COMPLETED","sponsor":"Fundacion SEIMC-GESIDA","startDate":"2023-05-26","conditions":"HIV Infections, Fatty Liver Disease","enrollment":63},{"nctId":"NCT05729568","phase":"PHASE2","title":"A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2023-05-15","conditions":"HIV Infection","enrollment":83},{"nctId":"NCT04648046","phase":"PHASE1, PHASE2","title":"CAR-T Cells for HIV Infection","status":"RECRUITING","sponsor":"Steven Deeks","startDate":"2021-03-01","conditions":"HIV Infections","enrollment":18},{"nctId":"NCT06214052","phase":"PHASE2","title":"VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2024-02-07","conditions":"HIV Infections","enrollment":22},{"nctId":"NCT00796263","phase":"PHASE3","title":"Antiretroviral Therapy for Acute and Chronic HIV Infection","status":"RECRUITING","sponsor":"SEARCH Research Foundation","startDate":"2009-05-13","conditions":"Acute HIV Infection, Chronic HIV Infection","enrollment":900},{"nctId":"NCT05585307","phase":"PHASE1","title":"Study of Novel Antiretrovirals in Participants With HIV-1","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2022-10-26","conditions":"HIV-1-infection","enrollment":49},{"nctId":"NCT05890963","phase":"PHASE1","title":"10E8.4/iMab Bispecific Antibody and VRC07-523LS Monoclonal Antibody in HIV-infected Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"David Ho","startDate":"2023-11-28","conditions":"HIV-1-infection","enrollment":20},{"nctId":"NCT00167674","phase":"PHASE2","title":"ARVs to Prevent Breastmilk HIV:Viral and Immune Responses","status":"COMPLETED","sponsor":"University of Washington","startDate":"2003-11-03","conditions":"HIV Infections","enrollment":58},{"nctId":"NCT01634477","phase":"","title":"Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort Study","status":"COMPLETED","sponsor":"Thai Red Cross AIDS Research Centre","startDate":"2010-01","conditions":"HIV Infection, Healthy","enrollment":816},{"nctId":"NCT05330143","phase":"PHASE2","title":"Study to Evaluate Safety, Tolerance and Efficacy of ASC22 Combined With ART in Subjects With HIV","status":"COMPLETED","sponsor":"Ascletis Pharmaceuticals Co., Ltd.","startDate":"2022-06-28","conditions":"HIV-1-infection, HIV Infections, PD-L1 Gene Mutation","enrollment":19},{"nctId":"NCT01614405","phase":"NA","title":"Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis","status":"TERMINATED","sponsor":"University of Alberta","startDate":"2012-06","conditions":"Primary Biliary Cirrhosis","enrollment":13},{"nctId":"NCT04272242","phase":"PHASE2","title":"Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-02-27","conditions":"HIV Infection, LTBI","enrollment":37},{"nctId":"NCT05646082","phase":"PHASE1","title":"Preliminary Assessment of Safety and Tolerability of Dostarlimab in Combination Antiretroviral Therapy (cART) Refractory HIV Associated Kaposi Sarcoma","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2023-05-26","conditions":"Refractory HIV Associated Kaposi Sarcoma","enrollment":20},{"nctId":"NCT02595866","phase":"PHASE1","title":"Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2016-04-04","conditions":"AIDS-Related Non-Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8","enrollment":58},{"nctId":"NCT02120352","phase":"PHASE2","title":"A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2014-04-28","conditions":"Infection, Human Immunodeficiency Virus, HIV Infections","enrollment":309},{"nctId":"NCT05769569","phase":"PHASE1","title":"Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission","status":"WITHDRAWN","sponsor":"Henry M. Jackson Foundation for the Advancement of Military Medicine","startDate":"2023-09-01","conditions":"HIV-1-infection","enrollment":""},{"nctId":"NCT00867048","phase":"PHASE4","title":"Strategic Timing of Antiretroviral Treatment","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2009-04-15","conditions":"HIV Infection","enrollment":4688},{"nctId":"NCT05925140","phase":"PHASE1","title":"LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients","status":"UNKNOWN","sponsor":"Lebanese University","startDate":"2020-03-28","conditions":"COVID-19, Hospitalized COVID-19 Patients","enrollment":1000},{"nctId":"NCT04147325","phase":"","title":"A Study to Evaluate Virologic Response in Participants Newly Diagnosed With HIV-1","status":"COMPLETED","sponsor":"Janssen-Cilag Farmaceutica Ltda.","startDate":"2019-12-17","conditions":"HIV","enrollment":105},{"nctId":"NCT05077930","phase":"PHASE2","title":"Convalescent Plasma Therapy for Hospitalized Patients With COVID-19","status":"COMPLETED","sponsor":"Tânia Portella Costa","startDate":"2022-01-06","conditions":"COVID-19, Convalescent Plasma, SARS-CoV-2","enrollment":38},{"nctId":"NCT02336074","phase":"PHASE2","title":"Research In Viral Eradication of HIV Reservoirs","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2015-11-27","conditions":"HIV","enrollment":60},{"nctId":"NCT00106171","phase":"PHASE4","title":"Anti-HIV Medications for People Recently Infected With HIV","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2005-05","conditions":"HIV Infections","enrollment":113},{"nctId":"NCT00955968","phase":"PHASE4","title":"IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum Women","status":"COMPLETED","sponsor":"International Maternal Pediatric Adolescent AIDS Clinical Trials Group","startDate":"2010-01-01","conditions":"HIV Infection","enrollment":1653},{"nctId":"NCT00775606","phase":"PHASE4","title":"Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease","status":"TERMINATED","sponsor":"Rush University Medical Center","startDate":"2008-10","conditions":"Acquired Immune Deficiency Syndrome","enrollment":15},{"nctId":"NCT03208231","phase":"PHASE1, PHASE2","title":"Evaluating the Safety and Antiviral Activity of Monoclonal Antibody VRC01 in Infants With HIV Receiving Combination Antiretroviral Therapy","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-08-06","conditions":"HIV Infections","enrollment":61},{"nctId":"NCT00289952","phase":"PHASE2","title":"Valproic Acid and Its Effects on HIV Latent Reservoirs","status":"COMPLETED","sponsor":"Jean-Pierre Routy","startDate":"2006-06","conditions":"HIV Infections","enrollment":50},{"nctId":"NCT01013415","phase":"PHASE1","title":"CD4-ZETA Gene Modified T Cells With and Without Exogenous Interleukin-2 (IL-2) In HIV Patients","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2001-09","conditions":"HIV-1 Infections","enrollment":17},{"nctId":"NCT00145795","phase":"PHASE4","title":"A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2004-04","conditions":"HIV Infections","enrollment":20},{"nctId":"NCT00000891","phase":"PHASE2","title":"Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":34},{"nctId":"NCT00001075","phase":"NA","title":"The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":55},{"nctId":"NCT00270205","phase":"PHASE1, PHASE2","title":"Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAART","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-01","conditions":"HIV Infections","enrollment":28},{"nctId":"NCT00614640","phase":"PHASE1, PHASE2","title":"Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT00107549","phase":"PHASE1","title":"Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":20},{"nctId":"NCT00076518","phase":"PHASE2","title":"The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections, Hypertriglyceridemia","enrollment":100},{"nctId":"NCT00013871","phase":"NA","title":"Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections, Hepatitis B, Measles","enrollment":300},{"nctId":"NCT00125983","phase":"PHASE2","title":"Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections, Pregnancy","enrollment":32},{"nctId":"NCT00051090","phase":"NA","title":"Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections, Hepatitis B","enrollment":""},{"nctId":"NCT00257127","phase":"NA","title":"Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV Drugs","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-02","conditions":"HIV Infections","enrollment":101},{"nctId":"NCT00006066","phase":"PHASE1","title":"Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":92},{"nctId":"NCT00050921","phase":"NA","title":"Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":60},{"nctId":"NCT00000943","phase":"NA","title":"A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":50},{"nctId":"NCT00000899","phase":"PHASE1","title":"A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":10},{"nctId":"NCT00000895","phase":"NA","title":"A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"Mycobacterium Avium-intracellulare Infection, HIV Infections","enrollment":85},{"nctId":"NCT00872872","phase":"NA","title":"Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)","status":"COMPLETED","sponsor":"Thai Red Cross AIDS Research Centre","startDate":"2008-05","conditions":"NVP Plasma Level, NVP Related Mutation, 3TC Related Mutation","enrollment":30},{"nctId":"NCT04138199","phase":"","title":"A Study to Assess Effectiveness and Safety of Fixed Dose Combination of Lopinavir/Ritonavir (LPV/r) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients After Switching From Kaletra in the Routine Clinical Settings of Russian Federation","status":"TERMINATED","sponsor":"AbbVie","startDate":"2019-11-01","conditions":"HIV-1 Infection","enrollment":239},{"nctId":"NCT02707861","phase":"PHASE3","title":"Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1","status":"COMPLETED","sponsor":"TaiMed Biologics Inc.","startDate":"2016-03","conditions":"HIV","enrollment":79},{"nctId":"NCT02431975","phase":"PHASE4","title":"Latency and Early Neonatal Provision of Antiretroviral Drugs Clinical Trial","status":"COMPLETED","sponsor":"Columbia University","startDate":"2015-08","conditions":"HIV","enrollment":73},{"nctId":"NCT00511056","phase":"","title":"Adherence and Risk Behaviour in Patients With HIV Infection Receiving Antiretroviral Therapy","status":"COMPLETED","sponsor":"The HIV Netherlands Australia Thailand Research Collaboration","startDate":"2007-09","conditions":"HIV Infections","enrollment":700},{"nctId":"NCT01225406","phase":"","title":"Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children","status":"COMPLETED","sponsor":"The HIV Netherlands Australia Thailand Research Collaboration","startDate":"2010-08","conditions":"This Study is Designed to Collect Treatment Data of Thai Children on Third Line ARV Therapy","enrollment":56},{"nctId":"NCT01428596","phase":"PHASE1","title":"Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects","status":"UNKNOWN","sponsor":"GeneCure Biotechnologies","startDate":"2010-09","conditions":"HIV Infections","enrollment":30},{"nctId":"NCT00267865","phase":"PHASE2","title":"Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2006-09-14","conditions":"AIDS-Related-Primary Central Nervous System Lymphoma","enrollment":12},{"nctId":"NCT04297501","phase":"","title":"Gut Microbiota Changes of HIV Patients Before and After One Year of ART","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2018-03-01","conditions":"HIV Infections","enrollment":50},{"nctId":"NCT04041362","phase":"PHASE2","title":"the Study to Evaluate the Safety of UB-421 in Combination With Antiretroviral Therapy (ART) and the Efficacy in Reduction of HIV Viral Load and Proviral DNA as Compared to ART Alone in ART-experienced Viremic HIV-1 Patients","status":"WITHDRAWN","sponsor":"United BioPharma","startDate":"2020-04","conditions":"HIV-1 Infection","enrollment":""},{"nctId":"NCT00711230","phase":"PHASE2","title":"Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients","status":"COMPLETED","sponsor":"Genetic Immunity","startDate":"2008-04","conditions":"HIV Infection","enrollment":36},{"nctId":"NCT00339456","phase":"PHASE3","title":"Intermittent Versus Continuous HAART (Highly Active Antiretroviral Therapy) for Treating Chronic HIV Infected Patients in Uganda","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2002-08-21","conditions":"HIV","enrollment":155},{"nctId":"NCT00001899","phase":"","title":"Immune and Viral Status of HIV-Infected Patients After Stopping Combination Antiretroviral Therapy","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"1998-12-16","conditions":"HIV Infection","enrollment":38},{"nctId":"NCT00518154","phase":"PHASE2","title":"Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune Response","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2007-09","conditions":"HIV Infections","enrollment":7},{"nctId":"NCT00577681","phase":"","title":"Understanding the Increased Risk of Cardiovascular Disease in People With HIV","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2002-01","conditions":"HIV Infections","enrollment":5472},{"nctId":"NCT04140461","phase":"PHASE3","title":"AmB Dose for Cryptococcal Meningitis","status":"UNKNOWN","sponsor":"Shanghai Public Health Clinical Center","startDate":"2020-01-02","conditions":"Cryptococcal Meningitis, HIV Infections","enrollment":40},{"nctId":"NCT00043641","phase":"","title":"HIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2002-07-26","conditions":"HIV Infections","enrollment":73},{"nctId":"NCT01229761","phase":"PHASE2","title":"Study to Improve Survival Among HIV-Exposed Infants in Botswana","status":"COMPLETED","sponsor":"Harvard School of Public Health (HSPH)","startDate":"2011-05","conditions":"HIV Infections, Neutropenia, Anemia","enrollment":3724},{"nctId":"NCT01488942","phase":"NA","title":"Use of Incentives to Retain Drug Users in HIV Therapy","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2012-12","conditions":"HIV Infection","enrollment":139},{"nctId":"NCT02581202","phase":"","title":"The Effectiveness of Dual Therapy (Lopinavir/Ritonavir + LamivudinE) in Treatment-Experienced HIV Infected Patients in the Russian Federation","status":"COMPLETED","sponsor":"AbbVie","startDate":"2015-12-21","conditions":"HIV-1 Infection","enrollment":216},{"nctId":"NCT02563509","phase":"PHASE1","title":"Reconstitution of HIV-specific Immunity Against HIV","status":"COMPLETED","sponsor":"Guangzhou 8th People's Hospital","startDate":"2016-01","conditions":"HIV","enrollment":30},{"nctId":"NCT02054286","phase":"PHASE1, PHASE2","title":"Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART).","status":"COMPLETED","sponsor":"Theravectys S.A.","startDate":"2012-12","conditions":"HIV Infection","enrollment":38},{"nctId":"NCT01227044","phase":"PHASE2, PHASE3","title":"Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention","status":"COMPLETED","sponsor":"Yale University","startDate":"2011-04","conditions":"Reduction in Heavy Drinking in Patients With HIV","enrollment":51},{"nctId":"NCT01752569","phase":"PHASE1, PHASE2","title":"A Study of Selumetinib in Patients With Kaposi's Sarcoma","status":"TERMINATED","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2012-06-15","conditions":"AIDS-related Kaposi's Sarcoma","enrollment":19},{"nctId":"NCT03838497","phase":"PHASE4","title":"Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Among HIV-infected Adults","status":"COMPLETED","sponsor":"Korea University Guro Hospital","startDate":"2015-04-02","conditions":"Streptococcal Pneumonia, HIV/AIDS","enrollment":70},{"nctId":"NCT00945282","phase":"PHASE2","title":"Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2009-10-20","conditions":"Infection, Human Immunodeficiency Virus","enrollment":8},{"nctId":"NCT01403051","phase":"PHASE2","title":"High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART","status":"COMPLETED","sponsor":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","startDate":"2011-09","conditions":"HIV-1 Infection","enrollment":167},{"nctId":"NCT02489461","phase":"PHASE2, PHASE3","title":"Efficacy, Safety and Optimal Dose of VM-1500 in Comparison to Efavirenz Added to Standard-of-care Antiretroviral Therapy","status":"COMPLETED","sponsor":"Viriom","startDate":"2014-08-05","conditions":"HIV-1-infection","enrollment":150},{"nctId":"NCT01262976","phase":"PHASE2","title":"Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-01-17","conditions":"Tuberculosis","enrollment":240},{"nctId":"NCT01697540","phase":"","title":"Management of Highly Active Anti-retroviral Therapy-related Hyperlipidemia Among HIV-infected Patients in Taiwan","status":"COMPLETED","sponsor":"Kaohsiung Medical University Chung-Ho Memorial Hospital","startDate":"2012-09","conditions":"HIV","enrollment":100},{"nctId":"NCT00428116","phase":"NA","title":"Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya","status":"TERMINATED","sponsor":"University of Washington","startDate":"2007-09","conditions":"HIV Infections","enrollment":140},{"nctId":"NCT00531986","phase":"PHASE4","title":"HIV - Monotherapy in Switzerland (MOST-ch)","status":"TERMINATED","sponsor":"Cantonal Hospital of St. Gallen","startDate":"2007-01","conditions":"HIV Infections","enrollment":60},{"nctId":"NCT02063880","phase":"NA","title":"Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART)","status":"COMPLETED","sponsor":"University of Washington","startDate":"2013-03","conditions":"Human Immunodeficiency Virus, Immune Reconstitution Inflammatory Syndrome","enrollment":183},{"nctId":"NCT00433030","phase":"","title":"Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand","status":"COMPLETED","sponsor":"Institut de Recherche pour le Developpement","startDate":"2007-01","conditions":"HIV Infections","enrollment":2816},{"nctId":"NCT00991302","phase":"NA","title":"Durability of Adherence in Self-Management of HIV","status":"COMPLETED","sponsor":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","startDate":"2010-01","conditions":"HIV Infections","enrollment":172},{"nctId":"NCT02624453","phase":"NA","title":"Pre-Antiretroviral Therapy (ART) Cryptococcal Antigen Screening in AIDS","status":"UNKNOWN","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2015-07","conditions":"Cryptococcal Meningitis","enrollment":186},{"nctId":"NCT00528957","phase":"PHASE3","title":"Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2006-12-28","conditions":"HIV Infections","enrollment":97},{"nctId":"NCT02794545","phase":"NA","title":"Functional Cure Study of HIV-infected Patients","status":"COMPLETED","sponsor":"Kaohsiung Medical University Chung-Ho Memorial Hospital","startDate":"2014-10","conditions":"HIV","enrollment":20},{"nctId":"NCT01924286","phase":"PHASE3","title":"Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone","status":"COMPLETED","sponsor":"University of Cape Town","startDate":"2013-08-30","conditions":"Immune Reconstitution Inflammatory Syndrome, HIV, Tuberculosis","enrollment":240},{"nctId":"NCT00783614","phase":"PHASE2","title":"Aspirin and Antiretroviral Therapy in HIV Infected Patients","status":"TERMINATED","sponsor":"Hennepin Healthcare Research Institute","startDate":"2008-10","conditions":"HIV Infection","enrollment":22},{"nctId":"NCT00705926","phase":"PHASE1","title":"Effectiveness of Antiretroviral Therapy During Acute HIV Infection","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2008-10","conditions":"HIV Infections","enrollment":25},{"nctId":"NCT02527096","phase":"PHASE2","title":"A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir®) and Dolutegravir (Tivicay®) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Active Antiretroviral Therapy (HAART) (ANRS 167 Lamidol)","status":"COMPLETED","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2015-09-17","conditions":"HIV-1 Infection","enrollment":110},{"nctId":"NCT01009749","phase":"NA","title":"Motivational Enhancement System for Adherence","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2009-08","conditions":"HIV","enrollment":76},{"nctId":"NCT00009256","phase":"","title":"Analysis of HIV Genetic Variation in Patients Before Beginning Highly Active Antiretroviral Therapy","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2000-04-13","conditions":"HIV Infection","enrollment":65},{"nctId":"NCT00710593","phase":"PHASE2","title":"Impact of a Human Papilloma Virus (HPV) Vaccine in HIV-Infected Young Women","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2008-02","conditions":"HIV Infection","enrollment":99}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":12264,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Highly active antiretroviral therapy","genericName":"Highly active antiretroviral therapy","companyName":"PETHEMA Foundation","companyId":"pethema-foundation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"HAART uses a combination of antiretroviral drugs from different classes to suppress HIV replication by targeting multiple steps of the viral lifecycle simultaneously. Used for HIV-1 infection (treatment and suppression), Prevention of mother-to-child HIV transmission, Post-exposure prophylaxis (PEP) in certain regimens.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}